Stevanato Group SpA (STVN) - Total Assets

Latest as of December 2025: $2.54 Billion USD

Based on the latest financial reports, Stevanato Group SpA (STVN) holds total assets worth $2.54 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See STVN total equity for net asset value and shareholders' equity analysis.

Stevanato Group SpA - Total Assets Trend (2018–2025)

This chart illustrates how Stevanato Group SpA's total assets have evolved over time, based on quarterly financial data.

Stevanato Group SpA - Asset Composition Analysis

Current Asset Composition (December 2025)

Stevanato Group SpA's total assets of $2.54 Billion consist of 36.8% current assets and 63.3% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 5.1%
Accounts Receivable $542.17 Million 21.3%
Inventory $268.09 Million 10.5%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $36.85 Million 1.5%
Goodwill $49.96 Million 2.0%

Asset Composition Trend (2018–2025)

This chart illustrates how Stevanato Group SpA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Stevanato Group SpA market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Stevanato Group SpA's current assets represent 36.8% of total assets in 2025, a decrease from 50.5% in 2018.
  • Cash Position: Cash and equivalents constituted 5.1% of total assets in 2025, down from 9.5% in 2018.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 10.0% in 2018.
  • Asset Diversification: The largest asset category is accounts receivable at 21.3% of total assets.

Stevanato Group SpA Competitors by Total Assets

Key competitors of Stevanato Group SpA based on total assets are shown below.

Company Country Total Assets
Teleflex Incorporated
NYSE:TFX
USA $6.95 Billion
Touchstone International Medical Science Co Ltd
SHG:688013
China CN¥676.02 Million
Nyxoah
BR:NYXH
Belgium €93.60 Million
Crossject
PA:ALCJ
France €31.38 Million
Ansell Ltd
AU:ANN
Australia AU$3.32 Billion
Nanosonics Ltd
AU:NAN
Australia AU$272.48 Million
SDI Ltd
AU:SDI
Australia AU$141.20 Million
Austco Healthcare Ltd
AU:AHC
Australia AU$91.07 Million

Stevanato Group SpA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.74 1.84 1.61
Quick Ratio 1.24 1.33 1.12
Cash Ratio 0.00 0.00 0.00
Working Capital $398.83 Million $402.65 Million $186.98 Million

Stevanato Group SpA - Advanced Valuation Insights

This section examines the relationship between Stevanato Group SpA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.40
Latest Market Cap to Assets Ratio 0.37
Asset Growth Rate (YoY) 9.2%
Total Assets $2.54 Billion
Market Capitalization $944.48 Million USD

Valuation Analysis

Below Book Valuation: The market values Stevanato Group SpA's assets below their book value (0.37x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Stevanato Group SpA's assets grew by 9.2% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Stevanato Group SpA (2018–2025)

The table below shows the annual total assets of Stevanato Group SpA from 2018 to 2025.

Year Total Assets Change
2025-12-31 $2.54 Billion +9.19%
2024-12-31 $2.33 Billion +12.42%
2023-12-31 $2.07 Billion +24.82%
2022-12-31 $1.66 Billion +16.98%
2021-12-31 $1.42 Billion +46.58%
2020-12-31 $967.98 Million +9.73%
2019-12-31 $882.18 Million +12.87%
2018-12-31 $781.58 Million --

About Stevanato Group SpA

NYSE:STVN USA Medical Instruments & Supplies
Market Cap
$944.48 Million
Market Cap Rank
#9414 Global
#2469 in USA
Share Price
$19.00
Change (1 day)
+4.34%
52-Week Range
$13.43 - $27.95
All Time High
$35.39
About

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprisi… Read more